Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-16 pm EDT			5-day change	1st Jan Change
366.25 ^USD	+0.01%		-2.84%	+11.90%

Mar. 16	Tech vs. Turmoil
Mar. 16	Amgen, GSK Join TrumpRx.gov With Deep Drug Discounts	MT

Transcript : Amgen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-12-2026 05

Published on 02/12/2026 at 05:58 pm EST - Modified on 02/12/2026 at 07:25 pm EST

S&P Capital IQ

Presenter Speech
David Amsellem (Analysts)

All right, everyone. Good afternoon. This is David Amsellem from the Piper Sandler Biopharma Research team and a happy almost Friday to everyone listening in.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Amgen Inc.

Mar. 16	Tech vs. Turmoil
Mar. 16	Amgen, GSK Join TrumpRx.gov With Deep Drug Discounts	MT
Mar. 16	Facing the Wall of Worry
Mar. 13	GSK and Amgen to add medicines to TrumpRx, Fox Business reports	RE
Mar. 12	GRAIL, Inc. Announces Board Changes	CI
Mar. 12	GRAIL, Inc. Announces Chief Executive Officer Changes, Effective June 1, 2026	CI
Mar. 12	Grail CEO Bob Ragusa to retire, Josh Ofman named successor	RE
Mar. 11	Amgen Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-11-2026 09:20 AM
Mar. 10	Equinix, Inc. Appoints Olivier Leonetti as Chief Financial Officer, Effective March 16, 2026	CI
Mar. 09	Global drugmakers rush to boost US presence as tariff threat looms	RE
Mar. 09	LB Pharmaceuticals Inc Appoints Robert Lenz, M.D., Ph.D. to Board of Directors	CI
Mar. 05	Arcutis Biotherapeutics, Inc. Announces Promotion of Mas Matsuda to Executive Vice President, Chief Legal Officer, and Corporate Secretary	CI
Mar. 05	Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset	CI
Mar. 04	Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable June 5 to Holders of Record May 15	MT
Mar. 04	Amgen announces 2026 second quarter dividend	RE